Cargando…

BRAF V600E potentially determines “Oncological Resectability” for “Technically Resectable” colorectal liver metastases

Despite reports on poor survival outcomes after hepatectomy for colorectal liver metastases (CRLM) with BRAF V600E mutation (mBRAF) exist, the role of mBRAF testing for technically resectable cases remains unclear. A single‐center retrospective study was performed to investigate the survival outcome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Shin, Takahashi, Shinichiro, Nomura, Shogo, Kojima, Motohiro, Kudo, Masashi, Sugimoto, Motokazu, Konishi, Masaru, Gotohda, Naoto, Taniguchi, Hiroya, Yoshino, Takayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Researcher
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525127/ https://www.ncbi.nlm.nih.gov/pubmed/34535965 http://dx.doi.org/10.1002/cam4.4227

Ejemplares similares

Pancreas‐preserving resection of lower biliary tract adenocarcinoma: A coring‐out technique
por: Nishida, Yasunori, et al.
Publicado: (2017)

Early postoperative decrease of skeletal muscle mass predicts recurrence and poor survival after surgical resection for perihilar cholangiocarcinoma
por: Yasuta, Sho, et al.
Publicado: (2022)

Evaluation of liver function using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging based on a three-dimensional volumetric analysis system
por: Kudo, Masashi, et al.
Publicado: (2018)

Histological tumor necrosis in pancreatic cancer after neoadjuvant therapy
por: Kudo, Masashi, et al.
Publicado: (2022)

Liver functional assessment using time-associated change in the liver-to-spleen signal intensity ratio on enhanced magnetic resonance imaging: a retrospective study
por: Kudo, Masashi, et al.
Publicado: (2023)

Profiling the Tumour Immune Microenvironment in Pancreatic Neuroendocrine Neoplasms with Multispectral Imaging Indicates Distinct Subpopulation Characteristics Concordant with WHO 2017 Classification
por: Takahashi, Daigoro, et al.
Publicado: (2018)

Component with abundant immune‐related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis
por: Yagi, Naoki, et al.
Publicado: (2022)

Peptide vaccine as an adjuvant therapy for glypican‐3‐positive hepatocellular carcinoma induces peptide‐specific CTLs and improves long prognosis
por: Taniguchi, Masatake, et al.
Publicado: (2020)

Hepatocellular Carcinoma with Foamy Histiocyte-Like Appearance: A Deceptively Clear Cell Carcinoma Appearing Variant
por: Noro, Takuji, et al.
Publicado: (2010)

Predictive Factors for Anastomotic Leakage after Simultaneous Resection of Synchronous Colorectal Liver Metastasis
por: Nakajima, Kentaro, et al.
Publicado: (2011)

Relationships between physical and immunological tumor microenvironment in pancreatic ductal adenocarcinoma
por: Igata, Yu, et al.
Publicado: (2023)

Hypothyroidism and hypopituitarism as immune-related adverse events due to lenvatinib plus pembrolizumab therapy in the immediate postoperative period after laparoscopic hepatectomy for liver metastases from gastric cancer: a case report
por: Sasaki, Kimimasa, et al.
Publicado: (2021)

Rationale and design of the BRAVERY study (EPOC1701): a multicentre phase II study of eribulin in patients with BRAF V600E mutant metastatic colorectal cancer
por: Masuishi, Toshiki, et al.
Publicado: (2019)

Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adenocarcinoma
por: Okubo, Satoshi, et al.
Publicado: (2019)

NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases
por: Kobayashi, Shin, et al.
Publicado: (2023)

Neoadjuvant S-1 with concurrent radiotherapy followed by surgery for borderline resectable pancreatic cancer: study protocol for an open-label, multicentre, prospective phase II trial (JASPAC05)
por: Takahashi, Shinichiro, et al.
Publicado: (2017)

Relationship between surgical R0 resectability and findings of peripancreatic vascular invasion on CT imaging after neoadjuvant S-1 and concurrent radiotherapy in patients with borderline resectable pancreatic cancer
por: Yasuta, Sho, et al.
Publicado: (2020)

BIG BANG study (EPOC1703): multicentre, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy with binimetinib, encorafenib and cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer
por: Kotani, Daisuke, et al.
Publicado: (2020)

Clinical impact of radiofrequency ablation and stereotactic body radiation therapy for colorectal liver metastasis as local therapies for elderly, vulnerable patients
por: Gotohda, Naoto, et al.
Publicado: (2020)

The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation
por: Mitani, Seiichiro, et al.
Publicado: (2019)

Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAF(V600E)-Mutated Anaplastic Thyroid Carcinoma
por: Wang, Jennifer R., et al.
Publicado: (2019)

BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma
por: Wilmott, J S, et al.
Publicado: (2013)

Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy
por: Aoki, Yu, et al.
Publicado: (2023)

Genomic and prognostic heterogeneity among RAS/BRAF (V600E)/TP53 co‐mutated resectable colorectal liver metastases
por: Berg, Kaja C. G., et al.
Publicado: (2021)

Efficacy of Neoadjuvant Targeted Therapy for Borderline Resectable III B-D or IV Stage BRAF (V600) Mutation-Positive Melanoma
por: Czarnecka, Anna M., et al.
Publicado: (2021)

BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
por: Del Bufalo, Francesca, et al.
Publicado: (2018)

Novel stromal biomarker screening in pancreatic cancer patients using the in vitro cancer-stromal interaction model
por: Nishida, Yasunori, et al.
Publicado: (2020)

Encorafenib, binimetinib, and cetuximab in BRAF V600E–mutated colorectal cancer: an early post-marketing phase vigilance study
por: Sakata, Hidenori, et al.
Publicado: (2022)

The role of BRAF V600 mutation in melanoma
por: Ascierto, Paolo A, et al.
Publicado: (2012)

BRAF V600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis
por: Kudo, Ko, et al.
Publicado: (2022)

Acquired resistance to BRAF inhibition in BRAF(V600E) mutant gliomas
por: Yao, Tsun-Wen, et al.
Publicado: (2016)

Intraoperative peritoneal lavage cytology offers prognostic significance for gastric cancer patients with curative resection
por: Higaki, Eiji, et al.
Publicado: (2017)

Minilaparoscopic Colorectal Resections: Technical Note
por: Bona, S., et al.
Publicado: (2012)

Recognition and pathological features of periampullary region adenocarcinoma with an indeterminable origin
por: Komine, Ryuji, et al.
Publicado: (2021)

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study
por: Uutela, Aki, et al.
Publicado: (2022)

A case of mucinous cystic neoplasm of the liver: a case report
por: Nakayama, Yusuke, et al.
Publicado: (2015)

Immunohistochemical BRAF V600E Expression and Intratumor BRAF V600E Heterogeneity in Acral Melanoma: Implication in Melanoma-Specific Survival
por: Ito, Takamichi, et al.
Publicado: (2020)

BRAF V600K vs. BRAF V600E: a comparison of clinical and dermoscopic characteristics and response to immunotherapies and targeted therapies
por: Zengarini, Corrado, et al.
Publicado: (2022)

The immunological impact of preoperative chemoradiotherapy on the tumor microenvironment of pancreatic cancer
por: Okubo, Satoshi, et al.
Publicado: (2021)

BRAF Inhibition in BRAF(V600)-Mutant Gliomas: Results From the VE-BASKET Study
por: Kaley, Thomas, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jonmjvnrnmulqup6u0oh2tkrap